Syverson Strege & Co’s Sanofi SNY Stock Holding History

Syverson Strege & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-310	Closed	-$16.9K	–	532
2023 Q1	$16.9K	Buy	+310	New	+$15.1K	0.01%	202

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Syverson Strege & Co's SNY Position: Q2 2023 in Review

Syverson Strege & Co sold out of Sanofi (SNY) in Q2 2023, closing a stake of 310 shares — an estimated $16.9K sold.

Syverson Strege & Co first reported a position in SNY in Q1 2023 and held it in 1 quarter. The position peaked at $16.9K in Q1 2023. 672 funds tracked by Wall St. Rank hold SNY as of Q2 2023.

Syverson Strege & Co reported no remaining Sanofi position as of Q2 2023 after selling out during the quarter.
Syverson Strege & Co sold 310 Sanofi shares in Q2 2023, an estimated $16.9K.
Syverson Strege & Co first reported a position in Sanofi in Q1 2023 and held it in 1 quarter.
Syverson Strege & Co's Sanofi position peaked at $16.9K in Q1 2023.
672 funds tracked by Wall St. Rank held Sanofi as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.